--- title: "SinoMab Bioscience (3681) stock: news and investor profile" url: "https://aibio.space/companies/sinomab-bioscience/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "SinoMab Bioscience Ltd. (HKEX: 3681), Hong Kong. The directory classifies it as Biotechnology." --- 3681 SinoMab Bioscience Ltd. HKEX · Hong Kong # SinoMab Bioscience (3681) news SinoMab Bioscience Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 3681, recorded under Hong Kong. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest SinoMab Bioscience news We have not published a story on SinoMab Bioscience yet. When there is news, it will appear here. ## SinoMab Bioscience at a glance - **Ticker**: 3681 - **Listing**: HKEX - **Country**: Hong Kong ### Related companies - [Sirnaomics](https://aibio.space/companies/sirnaomics/) HKEX: 2257 - [China NT Pharma Group Co.](https://aibio.space/companies/china-nt-pharma/) HKEX: 1011 - [Genscript Biotech](https://aibio.space/companies/genscript-biotech/) HKEX: 1548 - [CPBIO Holding Company](https://aibio.space/companies/cpbio/) HKEX: 3839 - [Sino Biopharmaceutical](https://aibio.space/companies/sino-biopharmaceutical/) HKEX: 1177 - [Regent Pacific Group](https://aibio.space/companies/regent-pacific/) HKEX: 575 - [Shenzhen Neptunus Interlong Bio-Technique Co.](https://aibio.space/companies/shenzhen-neptunus-interlong-bio-technique/) HKEX: 8329 - [Grand Pharmaceutical Group](https://aibio.space/companies/grand-pharmaceutical/) HKEX: 512 ### Also on HKEX - [Modern Chinese Medicine Group Co.](https://aibio.space/companies/modern-chinese-medicine/) 1643 - [Alphamab Oncology](https://aibio.space/companies/alphamab-oncology/) 9966 - [China Health Group](https://aibio.space/companies/china-health/) 8225 - [Xuanzhu Biopharmaceutical Co.](https://aibio.space/companies/xuanzhu-biopharmaceutical/) 2575 - [SSY Group](https://aibio.space/companies/ssy/) 2005 - [Hua Medicine](https://aibio.space/companies/hua-medicine/) 2552 ## Questions about SinoMab Bioscience What is the ticker symbol of SinoMab Bioscience? SinoMab Bioscience Ltd. trades under the ticker 3681 on HKEX. Where is SinoMab Bioscience listed? SinoMab Bioscience Ltd. is listed on HKEX. Our directory also records these other listings: GETTEX:4VF. Which country or territory is SinoMab Bioscience listed under? Our directory records SinoMab Bioscience Ltd. under Hong Kong. What does SinoMab Bioscience do? Our directory classifies SinoMab Bioscience Ltd. as: Biotechnology. This is a directory classification, not a description of the pipeline. What is the ISIN of SinoMab Bioscience? The ISIN recorded for SinoMab Bioscience Ltd. is HK0000544194. Does aibio.space cover SinoMab Bioscience? aibio.space lists SinoMab Bioscience Ltd. among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to SinoMab Bioscience? Companies in our directory listed in the same country and business area as SinoMab Bioscience: Sirnaomics, China NT Pharma Group Co., Genscript Biotech, CPBIO Holding Company, Sino Biopharmaceutical, Regent Pacific Group. ## Investor discussion: SinoMab Bioscience Members talk about SinoMab Bioscience (3681). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at SinoMab Bioscience, newest first. Each line links the filing it comes from. 1. 2026-08-20 Mergers Transaction under the Listing Rules: (1) MAJOR TRANSACTION - DISPOSAL OF SUZHOU PROPERTY AND FACILITY; AND (2) NOTICE OF EXTRAORDINARY GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0821/2026082100003.pdf) 2. 2026-08-10 Mergers Transaction under the Listing Rules: FURTHER DELAY IN DESPATCH OF CIRCULAR FOR MAJOR TRANSACTION. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0810/2026081000326.pdf) 3. 2026-07-27 Mergers Transaction under the Listing Rules: DELAY IN DESPATCH OF CIRCULAR FOR MAJOR TRANSACTION. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0727/2026072700749.pdf) 4. 2026-07-06 Mergers Transaction under the Listing Rules: MAJOR TRANSACTION DISPOSAL OF SUZHOU PROPERTY AND FACILITY. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0706/2026070601885.pdf) 5. 2025-08-29 Financings Share or debt issue: COMPLETION OF SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0829/2025082902164.pdf) 6. 2025-08-15 Financings Share or debt issue: COMPLETION OF CERTAIN SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0815/2025081501418.pdf) 7. 2025-07-22 Financings Share or debt issue: SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0722/2025072201144.pdf) 8. 2025-05-29 Financings Share or debt issue: COMPLETION OF SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0529/2025052900985.pdf) 9. 2025-05-13 Financings Share or debt issue: SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0513/2025051301163.pdf) ## Press releases Headlines of SinoMab Bioscience's own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-09-28 HKEXnews [Notification Letter to Non-registered Shareholders and Reply Form](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0928/2026092800792.pdf) 2. 2026-09-28 HKEXnews [Notification Letter to Registered Shareholders and Reply Form](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0928/2026092800782.pdf) 3. 2026-09-18 HKEXnews [SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO 2025 ANNUAL REPORT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0918/2026091801186.pdf) 4. 2026-09-07 HKEXnews [POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 7 SEPTEMBER 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0907/2026090700572.pdf) 5. 2026-08-31 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0831/2026083102817.pdf) 6. 2026-08-20 HKEXnews [Documents on Display](https://www1.hkexnews.hk/listedco/listconews/sehk/dod/en.html) 7. 2026-08-20 HKEXnews [NOTICE OF EXTRAORDINARY GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0821/2026082100005.pdf) 8. 2026-08-20 HKEXnews [(1) MAJOR TRANSACTION - DISPOSAL OF SUZHOU PROPERTY AND FACILITY; AND (2) NOTICE OF EXTRAORDINARY GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0821/2026082100003.pdf) 9. 2026-08-18 HKEXnews [BOOK CLOSURE PERIOD FOR THE EXTRAORDINARY GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0818/2026081801631.pdf) 10. 2026-08-18 HKEXnews [RESIGNATION OF EXECUTIVE DIRECTOR](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0818/2026081801333.pdf) 11. 2026-08-10 HKEXnews [FURTHER DELAY IN DESPATCH OF CIRCULAR FOR MAJOR TRANSACTION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0810/2026081000326.pdf) 12. 2026-07-27 HKEXnews [DELAY IN DESPATCH OF CIRCULAR FOR MAJOR TRANSACTION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0727/2026072700749.pdf) 13. 2026-07-24 HKEXnews [GRANT OF SHARE OPTIONS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0724/2026072401284.pdf) 14. 2026-07-06 HKEXnews [MAJOR TRANSACTION DISPOSAL OF SUZHOU PROPERTY AND FACILITY](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0706/2026070601885.pdf) 15. 2026-07-03 HKEXnews [APPOINTMENT OF EXECUTIVE DIRECTOR](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0703/2026070302239.pdf) 16. 2026-06-12 HKEXnews [POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 12 JUNE 2026 AND APPOINTMENT OF NON-EXECUTIVE DIRECTOR](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0612/2026061202078.pdf) 17. 2026-05-14 HKEXnews [VOLUNTARY ANNOUNCEMENT PRESENTATION OF PRECLINICAL STUDIES OF ANTI-CGC ANTIBODY (hC2) AT SID ANNUAL MEETING 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0514/2026051401110.pdf) 18. 2026-04-27 HKEXnews [NOTICE OF 2026 ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0427/2026042701629.pdf) 19. 2026-04-01 HKEXnews [VOLUNTARY ANNOUNCEMENT FIRST PATIENT DOSED IN PHASE 2 CLINICAL TRIAL OF SM17 FOR ATOPIC DERMATITIS IN CHINA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0401/2026040102996.pdf) 20. 2026-03-31 HKEXnews [RESIGNATION OF NON-EXECUTIVE DIRECTORS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0331/2026033101699.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:3681 on TradingView](https://www.tradingview.com/symbols/HKEX-3681/). ## Listing details SinoMab Bioscience Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 3681, recorded under Hong Kong. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: SinoMab Bioscience Ltd. - **Ticker**: 3681 - **Listing**: HKEX - **Country or territory**: Hong Kong - **Business scope**: Biotechnology - **ISIN**: HK0000544194 - **Other listed symbols**: GETTEX:4VF - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-3681/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/sinomab-bioscience/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "SinoMab Bioscience (3681) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/sinomab-bioscience/